Sign in

CIK 0001674416 · Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
operating
EIN
473173478
Phone
6173154600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,881,673
in 7 filings, $1.5M under 10b5-1 plans

Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Kulkarni Samarth −$2.6M Chief Executive Officer sold 14% of stake
  2. KASINGER JAMES R. −$797K General Counsel and Secretary sold 12% of stake
  3. Behbahani Ali −$781K Director sold 45% of stake
  4. George Simeon −$720K Director sold 48% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-29 Kulkarni Samarth Chief Executive Officer Sale −19,719 $44.37 $875K 392,658
2023-03-29 Kulkarni Samarth Chief Executive Officer Sale −5,281 $44.78 $237K 387,377
2023-03-29 Kulkarni Samarth Chief Executive Officer Option exercise · Stock Option (Right to Buy) −25,000 129,582
2023-03-14 Prasad Raju Chief Financial Officer Grant or award · Restricted Stock Units +40,000 40,000
2023-03-14 Prasad Raju Chief Financial Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2023-03-13 Kulkarni Samarth Chief Executive Officer Shares withheld for taxes −5,358 $43.22 $232K 382,463
2023-03-13 Kulkarni Samarth Chief Executive Officer Shares withheld for taxes −4,086 $43.22 $177K 387,377
2023-03-13 KASINGER JAMES R. General Counsel and Secretary Shares withheld for taxes −1,283 $43.22 $55K 53,616
2023-03-13 KASINGER JAMES R. General Counsel and Secretary Shares withheld for taxes −1,022 $43.22 $44K 54,844
2023-03-11 Kulkarni Samarth Chief Executive Officer Option exercise +9,000 391,463
2023-03-11 Kulkarni Samarth Chief Executive Officer Option exercise · Restricted Stock Units −9,000 18,000
2023-03-11 KASINGER JAMES R. General Counsel and Secretary Option exercise +2,250 55,866
2023-03-11 KASINGER JAMES R. General Counsel and Secretary Option exercise · Restricted Stock Units −2,250 4,500
2023-03-10 Kulkarni Samarth Chief Executive Officer Option exercise +11,833 387,821
2023-03-10 Kulkarni Samarth Chief Executive Officer Option exercise · Restricted Stock Units −11,833 0
2023-03-10 Kulkarni Samarth Chief Executive Officer Grant or award · Stock Option (Right to Buy) +188,000 188,000
2023-03-10 Kulkarni Samarth Chief Executive Officer Grant or award · Restricted Stock Units +77,000 77,000
2023-03-10 KASINGER JAMES R. General Counsel and Secretary Option exercise +2,833 54,899
2023-03-10 KASINGER JAMES R. General Counsel and Secretary Option exercise · Restricted Stock Units −2,833 0
2023-03-10 KASINGER JAMES R. General Counsel and Secretary Grant or award · Stock Option (Right to Buy) +40,000 40,000

Page 17 of 46 · 910 trades